Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems

被引:31
|
作者
Groom, Holly C. [1 ]
Crane, Bradley [1 ]
Naleway, Allison L. [1 ]
Weintraub, Eric [2 ]
Daley, Matthew F. [3 ]
Wain, Kris [3 ]
Kurilo, Mary Beth [4 ]
Burganowski, Rachael [5 ]
DeSilva, Malini B. [6 ]
Donahue, James G. [9 ]
Glenn, Sungching C. [10 ]
Goddard, Kristin [9 ]
Jackson, Michael L. [5 ]
Kharbanda, Elyse O. [6 ]
Lewis, Ned [9 ]
Lou, Yingbo [10 ]
Lugg, Marlene [8 ]
Scotty, Erica [7 ]
Sy, Lina S. [8 ]
Williams, Joshua T. B. [10 ]
Irving, Stephanie A. [1 ]
机构
[1] Kaiser Permanente Ctr Hlth Res, Portland, OR 97227 USA
[2] Ctr Dis Control & Prevent, Immunizat Safety Off, Atlanta, GA USA
[3] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA
[4] Amer Immunizat Registry Assoc, Washington, DC USA
[5] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA
[6] HealthPartners Inst, Minneapolis, MN USA
[7] Marshfield Clin Res Inst, Marshfield, WI USA
[8] Kaiser Permanente Southern Calif, Pasadena, CA USA
[9] Kaiser Permanente Northern Calif, Kaiser Permanente Vaccine Study Ctr, Oakland, CA USA
[10] Denver Hlth, Ambulatory Care Serv, Denver, CO USA
关键词
Vaccine safety; Immunization Information Systems; Vaccine data completeness; PRACTICES INTERIM RECOMMENDATION; UNITED-STATES; ADVISORY-COMMITTEE; COVID-19; VACCINE;
D O I
10.1016/j.vaccine.2021.12.048
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ABSTR A C T Background: The Vaccine Safety Datalink (VSD) uses vaccination data from electronic health records (EHR) at eight integrated health systems to monitor vaccine safety. Accurate capture of data from vacci-nes administered outside of the health system is critical for vaccine safety research, especially for COVID-19 vaccines, where many are administered in non-traditional settings. However, timely access and inclu-sion of data from Immunization Information Systems (IIS) into VSD safety assessments is not well under-stood. Methods: We surveyed the eight data-contributing VSD sites to assess: 1) status of sending data to IIS; 2) status of receiving data from IIS; and 3) integration of IIS data into the site EHR. Sites reported separately for COVID-19 vaccination to capture any differences in capacity to receive and integrate data on COVID-19 vaccines versus other vaccines. Results: All VSD sites send data to and receive data from their state IIS. All eight sites (100%) routinely integrate IIS data for COVID-19 vaccines into VSD research studies. Six sites (75%) also routinely integrate all other vaccination data; two sites integrate data from IIS following a reconciliation process, which can result in delays to integration into VSD datasets. Conclusions: COVID-19 vaccines are being administered in a variety of non-traditional settings, where IIS are commonly used as centralized reporting systems. All eight VSD sites receive and integrate COVID-19 vaccine data from IIS, which positions the VSD well for conducting quality assessments of vaccine safety. Efforts to improve the timely receipt of all vaccination data will improve capacity to conduct vaccine safety assessments within the VSD. (c) 2021 Elsevier Ltd. All rights reserved.
引用
收藏
页码:752 / 756
页数:5
相关论文
共 50 条
  • [31] Vaccine and Immunization Surveillance in Ontario (VISION) - Using linked health administrative databases to monitor vaccine safety
    Wilson, Kumanan
    Hawken, Steven
    Kwong, Jeffrey C.
    Deeks, Shelley L.
    Crowcroft, Natasha S.
    Manuel, Douglas
    VACCINE, 2012, 30 (43) : 6115 - 6120
  • [32] Tree-based data mining for safety assessment of first COVID-19 booster doses in the Vaccine Safety Datalink
    Yih, Katherine
    Daley, Matthew F.
    Duffy, Jonathan
    Fireman, Bruce
    McClure, David
    Nelson, Jennifer
    Qian, Lei
    Smith, Ning
    Vazquez-Benitez, Gabriela
    Weintraub, Eric
    Williams, Joshua T. B.
    Xu, Stanley
    Maro, Judith C.
    VACCINE, 2023, 41 (02) : 460 - 466
  • [33] Monitoring vaccine safety during measles mass immunization campaigns: Clinical and programmatic issues
    Pless, RP
    Bentsi-Enchill, AD
    Duclos, P
    JOURNAL OF INFECTIOUS DISEASES, 2003, 187 : S291 - S298
  • [34] A Vaccine Study Design Selection Framework for the Postlicensure Rapid Immunization Safety Monitoring Program
    Baker, Meghan A.
    Lieu, Tracy A.
    Li, Lingling
    Hua, Wei
    Qiang, Yandong
    Kawai, Alison Tse
    Fireman, Bruce H.
    Martin, David B.
    Nguyen, Michael D.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2015, 181 (08) : 608 - 618
  • [35] Tinnitus after COVID-19 vaccination: Findings from the vaccine adverse event reporting system and the vaccine safety datalink
    Yih, W. Katherine
    Duffy, Jonathan
    Su, John R.
    Bazel, Samaneh
    Fireman, Bruce
    Hurley, Laura
    Maro, Judith C.
    Marquez, Paige
    Moro, Pedro
    Nair, Narayan
    Nelson, Jennifer
    Smith, Ning
    Sundaram, Maria
    Vasquez-Benitez, Gabriela
    Weintraub, Eric
    Xu, Stanley
    Shimabukuro, Tom
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2024, 45 (06)
  • [36] Seizures Following DTP or MMR Vaccination: Results from the Vaccine Safety Datalink Study † 513
    Robert L Davis
    William Barlow
    Robert S Thompson
    Robert Chen
    Frank DeStefano
    Pediatric Research, 1998, 43 (Suppl 4) : 90 - 90
  • [37] Estimating Vaccine Hesitancy in Colorado by Using Immunization Information System Data
    Campbell, Kimberly
    Severson, Rachel
    PUBLIC HEALTH REPORTS, 2022, : 806 - 811
  • [38] Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials
    Joffe, Steven
    Babiker, Abdel
    Ellenberg, Susan S.
    Fix, Alan
    Griffin, Marie R.
    Hunsberger, Sally
    Kalil, Jorge
    Levine, Myron M.
    Makgoba, Malegapuru W.
    Moore, Renee H.
    Tsiatis, Anastasios A.
    Whitley, Richard
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (12): : 1995 - 2000
  • [39] Vaccine Safety Monitoring Systems in Developing Countries: An Example of the Vietnam Model
    Ali, Mohammad
    Rath, Barbara
    Vu Dinh Thiem
    CURRENT DRUG SAFETY, 2015, 10 (01) : 60 - 67
  • [40] Safety Data on Meningococcal Polysaccharide Vaccine from the Vaccine Adverse Event Reporting System
    Ball, R
    Braun, MM
    Mootrey, GT
    CLINICAL INFECTIOUS DISEASES, 2001, 32 (09) : 1273 - 1280